It's March nationwide. CDC's latest count showing 982 cases in 26 states so far this year. The latest hot spot is Florida with 92 cases.The majority associated with a Maria University near Naples. >> I got very dehydrated. >> Student Bla1 Carney telling our affiliate WBBH he was one of the first on campus to be diagnosed with the highly contagious virus last month.A combination of measles and strep throat, he said, sent him to the emergency department. >> I just progressively got worse until I was in the ER ...

Core Insights - CVS Health has initiated the offering of the measles-mumps-rubella (MMR) vaccine in South Carolina in response to a current outbreak, with both CVS Pharmacy stores and MinuteClinic locations participating in the vaccination effort [1][6] Group 1: Stock Performance - Following the announcement of the vaccination initiative, CVS shares experienced a rise of 2.4% [2][9] - Over the past three months, CVS shares have gained 70.4%, significantly outperforming the industry growth of 5.4% [12] Group 2: Business Operations - CVS Health's Pharmacy and Consumer Wellness segment operates over 9,000 retail locations and reported a revenue growth of 12% year over year in Q3 2025 [3][9] - The company has a current market capitalization of $100.82 billion and an estimated earnings growth rate of 22.7% for 2025, surpassing the industry average of 16.7% [4] Group 3: Vaccination Initiative Details - The MMR vaccine is available at more than 200 CVS locations in South Carolina, with the vaccine being effective if administered within 72 hours of exposure to measles [6][10] - Patients aged three and older can receive the MMR vaccine, and CVS staff can assist in determining insurance coverage for the vaccine [10] Group 4: Strategic Developments - Aetna, a subsidiary of CVS Health, is implementing a generative AI chat experience to enhance member navigation of benefits, aligning with a shift towards a more consumer-centric health care approach [11]

Do you know Andy Wakefield. You absolutely should. He's a buddy and one-time business partner of Robert F.Kennedy Jr. . This is Wakefield and his friend RFK talking on Instagram in 2020. Back then, Kennedy was an antivaccine activist, not yet running HHS.And Wakefield was a disgraced researcher, the architect of the antivaccine movement's foundational lie that the MMR vaccine causes autism. Wakefield was a British gastroenterenterologist in the9s who published a study in the Lancet claiming he'd found a con ...

Welcoming CDC director Jim O'Neal is calling on vaccine makers to split up the combined MMR vaccine. In a post on X yesterday, O'Neal endorsed President Trump's earlier call to split the measles, MS, and Reubella vaccine into three separate injections. The post came just hours after O'Neal signed off on a vaccine advisory panel recommendation against getting the vaccine before the age of four.Let's bring in NBC News medical contributor Dr. . Vin Gupta. Uh so doctor, what would be the problem with this sugge ...

Group 1 - A recent poll indicates that 1 in 6 American parents have delayed or skipped childhood vaccinations, excluding flu and COVID-19 shots, with 9% admitting to skipping core vaccinations like polio and MMR [1][2] - The primary reason for vaccine hesitancy among parents is a lack of trust, with 86% citing concerns about potential side effects and risks, while 12% mentioned insurance coverage issues or high costs [2] - The CDC emphasizes that the childhood vaccine schedule is crucial for saving lives and protecting children during their most vulnerable years [3][4] Group 2 - The Affordable Care Act (ACA) prohibits individual health insurers from denying coverage or charging higher premiums based on vaccination history [4] - Employer-sponsored health insurance can be more complex, as employers may impose premium surcharges related to vaccination status, particularly highlighted during the COVID-19 pandemic [5] - Delta Airlines previously implemented a $200 surcharge for unvaccinated employees to offset COVID-19 treatment costs, which was later removed as case numbers declined [6]

Vaccine Industry Insights - A new RFK Junior-backed vaccine panel is advocating for restrictions on the MMR vaccine for children under four, with a vote on hepatitis B vaccine recommendations postponed due to insufficient data [1] - Concerns have been raised regarding the profitability of vaccine companies like Merck, Moderna, and Pfizer, with a general sentiment that the value of vaccines has diminished [3][4] - Moderna is facing significant challenges, including a potential revenue decline and a lawsuit that could cost the company between $2 billion to $3 billion, which it may struggle to afford [8][9] Regulatory Environment - The FDA is perceived to be actively working on drug approvals, although there are concerns about the lack of expected approvals impacting investor sentiment [6][7] - There is a growing apprehension regarding potential price controls on pharmaceuticals as the administration approaches midterm elections, which could negatively affect the industry [10][11] Advertising and Market Dynamics - The advertising landscape for pharmaceuticals is under scrutiny, with concerns about how direct-to-consumer advertising impacts the industry, although investors currently do not view it as a major concern [12][13] - Despite the challenges, the biotech sector is viewed positively, with indications that drug development is increasing and the overall climate is improving [14][15]

Vaccine Policy & Regulation - The Advisory Committee on Immunization Practices (ACIP) has new members, some with anti-vaccine views or skepticism towards the COVID-19 vaccine, potentially influencing future decisions [1][2][3] - Discussions are focusing on the MMR (measles, mumps, rubella) and varicella (chickenpox) combined vaccine, specifically the risk of febrile seizures, which anti-vaxxers want to remove from the market [4][5] - There's a movement to remove thimerosal (a preservative) from the remaining 4% of vaccines (mostly adult flu vaccines) and alum (an aluminum salt adjuvant) from seven pediatric vaccines [7][8][9] - Removing alum could force manufacturers to reformulate vaccines, potentially leading to vaccine shortages due to lack of safe alternatives [9][10][11] - ACIP's involvement in issues traditionally handled by regulators raises concerns about settled science, particularly regarding thimerosal and alum [18][19] Vaccine Safety & Public Health - The combined MMR and varicella vaccine carries a small risk of febrile seizures, which can be mitigated by monitoring and treating fevers above 1005°F (3806°C) between days 5 and 14 post-vaccination; about 10% of children experience this reaction [4][5] - Declining MMR vaccination rates in over 50% of states, with some below 70%, are setting up risks for future measles outbreaks [26] - There are concerns that anti-vaccine sentiment, fueled by COVID-19 mandates, will have long-term consequences, leading to outbreaks of preventable diseases [24][25][26] Litigation & Industry Impact - Secretary Kennedy's actions are potentially setting up a litigation enterprise, aiming to link vaccines to autism and open the door to lawsuits under the Vaccine Injury Compensation Program [28][29][30][31] - This could drive vaccine manufacturers out of the market, as companies may choose to stop manufacturing vaccines due to potential lawsuits [31][32]